Ibere Pharmaceuticals
08/04/2021 | Press release | Distributed by Public on 08/04/2021 12:09
Letter dated August 4, 2021 from Marcum LLP (Form 8-K)
August 4, 2021
Securities and Exchange Commission
100 F Street, N.E.
Washington, DC 20549
Commissioners:
We have read the statements made by Ibere Pharmaceuticals under Item 4.01 of its Form 8-K dated August 4, 2021. We agree with the statements concerning our Firm in such Form 8-K; we are not in a position to agree or disagree with other statements of Ibere Pharmaceuticals contained therein.
Very truly yours,
/s/ Marcum LLP
Marcum LLP